English
Back
Download
Log in to access Online Inquiry
Back to the Top

China Resources Boya Bio-pharmaceutical Group's stock price ...

China Resources Boya Bio-pharmaceutical Group's stock price continues to drop despite healthier EPS and revenue growth, indicating a market readjustment of previous high expectations and possible influence of market uncertainties.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
1551 Views
Comment
Sign in to post a comment